Ding L., Chang M., Guo Y., Zhang L., Xue C., Yanagita T., Zhang T., Wang Y
This means it requires respect and careful protocol design, not casual use
Women who received concurrent menopause hormone therapy lost 35% more total body weight than those on tirzepatide alone 17% versus 14% at 15 months along with improved cardiometabolic outcomes
As a synthetic peptide with an extended half-life, GLP-3 consolidates these effects into a once-weekly injectable formulation studied in clinical trials
While one of the trials evaluated Orforglipron versus Dapagliflozin in 962 patients with type-2 diabetes inadequately controlled on Metformin, the other trial assessed Orforglipron versus placebo in 546 adults with type 2 diabetes and inadequate glycemic control with titrated insulin glargine
Medications like Ozempic, Mounjaro, Wegovy, and Zepboundpart of the GLP-1 receptor agonist classare widely used to support weight loss and manage type 2 diabetes